Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms:


| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 5 mg | $58 | In Stock | In Stock | |
| 10 mg | $97 | In Stock | In Stock | |
| 25 mg | $197 | In Stock | In Stock | |
| 50 mg | $329 | In Stock | In Stock | |
| 100 mg | $558 | In Stock | In Stock | |
| 1 mL x 10 mM (in DMSO) | $64 | In Stock | In Stock |

| Description | 5-Ph-IAA is an IAA derivative and a highly efficient, low-toxicity, reversible protein degradation ligand specifically designed for the AID2 system. AID2 induces rapid and effective depletion of mAID fusion proteins, enabling the study of protein function in living cells; it also exhibits antitumor activity. 5-Ph-IAA can be used in antitumor research. |
| In vitro | Methods: HCT116 cells (human colorectal cancer cell line) were treated with IAA (100 μM) or 5-Ph-IAA (1 μM) for 24 and 72 hours, followed by detection of cell cycle changes. Results: Treatment with 1 μM 5-Ph-IAA had no significant effect on the cell cycle. [1] |
| In vivo | Methods: CRISPR/Cas9 was used to knock in an AID tag downstream of the start codon of the endogenous Dcp2 gene, generating AID-Dcp2 mice. This strain was crossed with a systemically TIR1-expressing line. Embryos were collected 20 hours after intraperitoneal injection of 5 mg/kg 5-Ph-IAA. DCP2 protein levels were detected by Western blot, and phenotypes were observed. Results: Western Blot analysis revealed near-complete disappearance of DCP2 protein following 5-Ph-IAA treatment. Within 20 hours post-treatment, embryos exhibited phenotypes similar to Dcp2 knockout mice, demonstrating significantly accelerated protein degradation compared to conventional knockout Methods.[2] |
| Molecular Weight | 251.28 |
| Formula | C16H13NO2 |
| Cas No. | 168649-23-8 |
| Smiles | OC(=O)Cc1c[nH]c2ccc(cc12)-c1ccccc1 |
| Relative Density. | 1.291 g/cm3 (Predicted) |
| Storage | Store at low temperature Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 45 mg/mL (179.08 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 4.5 mg/mL (17.91 mM), Solution. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.